Categories AlphaGraphs, Health Care
Infographic: Vertex Pharmaceuticals (VRTX) 4Q20 Earnings Results
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported fourth quarter 2020 earnings results today.
Total revenues increased 15% year-over-year to $1.62 billion.
GAAP net income was up 4% to $604 million while EPS rose 3% to $2.30 per share. Adjusted net income rose 49% to $661 million, or $2.51 per share.
For the full year of 2021, product revenues are expected to be $6.7-6.9 billion.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Microsoft (MSFT) Q2 revenue up 20%, earnings beat estimates
Software giant Microsoft Corp. (NASDAQ: MSFT) on Tuesday reported higher revenues and earnings for the second quarter of 2022. The results also topped expectations. At $51.7 billion, second-quarter revenues were
NFLX Stock: What the slowdown in subscriber growth means for Netflix
When online platforms thrived on the unusually strong traffic growth during the shutdown, as home-bound people turned to video-streaming and gaming sites, there was speculation that the trend might reverse
FAST Stock: Fastenal’s long-term prospects intact. Should you invest now?
Production disruption and logistics issues continue to have a crippling effect on the industrial sector but the performance of companies, in general, has been mixed so far. Fastenal Company (NASDAQ:
